Clinical trial
A randomised, placebo controlled trial to study the effect of heme-arginate on heme-oxygenase-1 induction and renal function in recipients of deceased donor renal transplants.
Does treating the recipients of deceased donor kidneys with heme-arginate (HA) increase the amount of HO-1 protein in the recipient�s white blood cells compared to placebo treatment?
| Category | Value |
|---|---|
| Study start date | 2011-11-01 |